S.3068

Massachusetts S3068 protects patient safety by regulating the sale and labeling of non-FDA approved drugs.

Massachusetts S3068 aims to protect patient safety by regulating the sale and labeling of non-FDA approved drugs. The bill mandates specific labeling requirements for compounded drugs, including the name and contact information of the outsourcing facility, lot or batch number, dosage form, expiration date, and storage instructions. It prohibits retail pharmacies from reselling compounded medications and requires that such medications be dispensed only to the patient for whom they were compounded.